These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3363661)

  • 1. Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops.
    BenEzra D; Matamoros N; Cohen E
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):644-9. PubMed ID: 3363661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
    Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
    Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
    Ozcan AA; Ersoz TR; Dulger E
    Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].
    Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L
    Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
    Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of topical cyclosporine.
    Kaan G; Ozden O
    Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis.
    BenEzra D; Pe'er J; Brodsky M; Cohen E
    Am J Ophthalmol; 1986 Mar; 101(3):278-82. PubMed ID: 3953723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
    Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
    Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
    Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.
    Lambiase A; Minchiotti S; Leonardi A; Secchi AG; Rolando M; Calabria G; Orsoni J; Zola E; Ferreri G; Aragona P; Reibaldi A; Chisari G; Bonini S
    Ophthalmic Epidemiol; 2009; 16(1):38-41. PubMed ID: 19191180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
    Keklikci U; Dursun B; Cingu AK
    Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic disodium cromoglycate.
    Tierney DW
    J Am Optom Assoc; 1985 Dec; 56(12):928-31. PubMed ID: 3937847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
    Graue E
    Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.